Septerna, Inc. (SEPN) insider trading

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Ra Capital Management, L.p. entity

Director

—

$63.45M (2)

−$63.45M

725,443

1.55%

$27.29M

−67.3%

Third Rock Ventures V, L.P. entity

10% owner

—

$7.40M (2) scheduled

−$7.40M

6,068,391

13.00%

$228.26M

+2.5%

Samira Shaikhly

Chief People Officer

—

$2.80M (8) scheduled

−$2.80M

793

0.0017%

$29.83K

0.0%

Elizabeth Bhatt

President and COO

—

$1.60M (9) scheduled

−$1.60M

174,209

0.3732%

$6.55M

0.0%

Daniel D. Long

SVP, Drug Discovery

—

$951.33K (8) scheduled

−$951.33K

96,412

0.2066%

$3.63M

−3.5%

Third Rock Ventures VI, L.P. entity

10% owner

—

4,211,659

9.02%

$158.42M

+33.6%

Jeffrey Finer

Chief Executive Officer

—

826,907

1.77%

$31.10M

+9.5%

Alan Ezekowitz

Director

—

117,420

0.2516%

$4.42M

+574.1%

Gil M Labrucherie

Chief Financial Officer

—

40,000

0.0857%

$1.50M

—

Uwe Klein

SVP, Biological Sciences

—

23,008

0.0493%

$865.43K

—

Septerna, Inc.

What the insiders did Net selling

By person